Novo Nordisk (NVO) is seeking lower prices from suppliers to lower its own expenses to remain competitive with rivals in the weight-loss drug market, news outlets reported Thursday.
Bloomberg cited a statement from the company that it was seeking lower raw materials costs in order to compete commercially.
The Danish news outlet Finans, which first reported the news, said the suppliers were told if they didn't comply it could hut future deals.
Novo Nordisk did not immediately reply to MT Newswires' request for comment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments